Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for ...

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

A new study compares body mass index (BMI) with body fat percentage and finds the latter is far more reliable in predicting ...

The 61-year-old man received a new kidney from a deceased donor after being diagnosed with “nephrosclerosis-related end-stage ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Researchers are also looking into whether GLP-1 medications like Ozempic and Wegovy ... also bring down smoking rates and reduce other smoking health impacts such as heart disease, COPD, high blood ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term habits still matter most.

At first, Chinese pharmaceutical companies rushed to make similar versions of blockbuster weight-loss drugs, such as Wegovy and Ozempic, that have taken ... says ecnoglutide also improved risk factors ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.